Five-year open-label extension study of safety and efficacy of etanercept in children and adolescents with moderate to severe plaque psoriasis Meeting Abstract

sustainable development goals

publication date

  • May 1, 2016

webpage

published in

start page

  • AB251

end page

  • AB251

volume

  • 74

issue

  • 5